Market Cap

Egetis Therapeutics AB Market Capitalization:

€199.4 Million

EUR as of Jan. 1, 2026

US$234.1 Million

business Egetis Therapeutics AB Company Profile

Egetis Therapeutics AB Main Stock Listing

FSX: P0F

Market Capitalization History of Egetis Therapeutics AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Egetis Therapeutics AB market cap

Date Market Cap YoY Change
Jan. 1, 2026 €199.4 M 22.84%
Jan. 1, 2025 €162.3 M 10.87%
Jan. 1, 2024 €146.4 M 2.74%
Jan. 1, 2023 €142.5 M 16.58%
Jan. 1, 2022 €122.2 M -19.05%
Jan. 1, 2021 €151.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Egetis Therapeutics AB Categories

Sweden languages Healthcare languages Biotechnology
Sweden Healthcare Sweden Biotechnology

Stocks & Indices

Egetis Therapeutics AB has the following listings and related stock indices.


Stock: FSX: P0F

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.